The global miRNA tools and services market was valued at USD 417.69 million in 2024, and is estimated to grow to USD 498.34 million by 2025, ultimately reaching an impressive USD 2399.94 million by 2034. This expansion represents a CAGR of 19.34% from 2025 to 2034, highlighting the increasing adoption of miRNA technologies in diagnostics, drug discovery, and biomarker development.

Key Insights

• North America led the market in 2024 with a 44% revenue share.

• Asia Pacific is expected to register the highest CAGR during the forecast period.

• The miRNA detection & quantification tools segment dominated with 38% share in 2024.

• The miRNA sequencing & bioinformatics services segment is forecasted to grow the fastest.

---

Top Companies in the miRNA Tools and Services Market

Here’s a quick look at the leading companies revolutionizing the miRNA tools and services sector:

---

1. Thermo Fisher Scientific

• About: A global leader in life sciences solutions and clinical diagnostics.

• Products: TaqMan® MicroRNA assays, miRNA isolation kits, sequencing solutions.

• Market Cap: Approx. USD 200+ billion (as of 2025).

---

2. QIAGEN

• About: A pioneer in sample and assay technologies.

• Products: miScript miRNA PCR System, RNA purification kits, NGS panels.

• Market Cap: Around USD 10–12 billion.

---

3. Illumina

• About: Renowned for cutting-edge genomic sequencing platforms.

• Products: TruSeq Small RNA Library Prep, NGS services for miRNA.

• Market Cap: Over USD 30 billion.

---

4. Agilent Technologies

• About: A key player in analytical instrumentation and molecular diagnostics.

• Products: SureSelect RNA kits, miRNA profiling microarrays.

• Market Cap: Near USD 35 billion.

---

5. Bio-Rad Laboratories

• About: Specializes in clinical diagnostics and life sciences research.

• Products: qPCR systems, miRNA detection kits.

• Market Cap: Estimated at USD 10 billion.

---

6. Takara Bio

• About: A Japanese biotech innovator known for advanced gene technologies.

• Products: SMARTer smRNA-Seq Kits, RNA isolation tools.

• Market Cap: Close to USD 2 billion.

---

7. Horizon Discovery (Revvity)

• About: Offers gene editing and RNAi products, now part of Revvity.

• Products: Synthetic RNA products, screening platforms.

• Market Cap: Integrated within Revvity’s approx. USD 10 billion cap.

---

8. PerkinElmer / Revvity

• About: Specializes in diagnostics and life sciences instruments.

• Products: Bioinformatics for miRNA, miRNA detection assays.

• Market Cap: About USD 10 billion post-rebrand as Revvity.

---

9. Norgen Biotek

• About: Canadian company focused on RNA, DNA, and protein purification.

• Products: Total RNA purification kits, miRNA qPCR assays.

• Market Cap: Privately held.

---

10. Exiqon (Now QIAGEN)

• About: Previously known for miRNA profiling and detection tools.

• Products: Locked Nucleic Acid (LNA) probes, miRNA arrays.

• Market Cap: Now integrated under QIAGEN.

---

11. GeneCopoeia

• About: Offers molecular tools and gene function analysis products.

• Products: miRNA expression vectors, target validation kits.

• Market Cap: Privately held.

---

12. Bioline (Meridian Bioscience)

• About: A provider of molecular biology reagents, part of Meridian Bioscience.

• Products: SensiFAST™ SYBR kits, miRNA RT kits.

• Market Cap: Meridian was acquired for approx. USD 1.5 billion.

---

13. System Biosciences (SBI)

• About: Specializes in exosome and RNA tools.

• Products: miRNA detection kits, EV characterization platforms.

• Market Cap: Privately held.

---

14. Miltenyi Biotec

• About: A Germany-based biotech company known for cell and molecular research tools.

• Products: miRNA microarrays, isolation kits.

• Market Cap: Privately owned.

---

15. BioCat GmbH

• About: European distributor and developer of molecular biology products.

• Products: miRNA quantification tools, bioinformatics software.

• Market Cap: Private company.

---

16. LC Sciences

• About: Focused on microarray and sequencing services.

• Products: miRNA microarrays, NGS-based profiling.

• Market Cap: Privately held.

---

17. CD Genomics

• About: Provides sequencing, genotyping, and bioinformatics services.

• Products: Small RNA sequencing, custom miRNA panels.

• Market Cap: Private entity.

---

18. GenoSensor Corporation

• About: U.S.-based supplier of genomic research tools.

• Products: Microarray kits, miRNA profiling platforms.

• Market Cap: Private organization.

---

Future Trends in miRNA Tools and Services

• Integration with AI & bioinformatics will enhance data interpretation in miRNA profiling.

• Expansion of clinical applications, especially in oncology and neurological diseases.

• Increased investment in R&D for novel non-coding RNA biomarkers.

Request a customized case study tailored to your business needs and gain deeper insights
into healthcare market strategies: sales@towardshealthcare.com

---

Frequently Asked Questions (FAQs)

1. What is driving the growth of the miRNA tools and services market?

The rise in chronic diseases, personalized medicine demand, and advancements in NGS and bioinformatics are key growth drivers.

2. Which region is leading the miRNA market?

North America currently dominates, but Asia Pacific is projected to grow at the fastest rate through 2034.

3. Which segment holds the largest share in 2024?

The miRNA detection & quantification tools segment accounted for approximately 38% of revenue in 2024.

4. Who are the key players in the market?

Companies like Thermo Fisher Scientific, QIAGEN, Illumina, and Agilent Technologies lead the market alongside emerging players.

5. What are the most promising applications for miRNA technologies?

Diagnostics, cancer research, therapeutics, and biomarker development are among the most promising application areas.

Source : https://www.towardshealthcare.com/insights/mirna-tools-and-services-market-sizing

Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5897